Hangzhou Zhongtai Cryogenic Technology Corporation (300435) Fair Value & Analysis
Industrials · CN · Market cap 8.1B CNY
Fair value as of: Jul 9, 2026
From 24 valuation models · updated 32 days ago
Fair value updated Jul 9, 2026, revised from ¥24.52 to ¥15.37 (−37.3%) since Jun 24, 2026. Share price −20.5% over the past month.
A solid business, but screening 12% overvalued on our models.
What matters now
- Our model range runs from ¥11.53 (bear) to ¥19.07 (bull), base ¥15.37. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 71/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.
How to read this chart
60‑month range ¥9.20 – ¥34.86 · fair‑value band ¥11.53 – ¥19.07 · the ¥17.50 price screens above the ¥15.37 fair value. Dashed = 300-day average. As of Jul 9, 2026.
Analysis
Hangzhou Zhongtai Cryogenic Technology Corporation (300435) currently trades at ¥17.50, while our model-based Fair Value estimate is ¥15.37, implying the stock looks roughly 12.2% overvalued today. The Quality Score stands at 71/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Hangzhou Zhongtai Cryogenic Technology Corporation generated revenue of 2.6B CNY at a net margin of 15.1%. Revenue declined 21.3% year over year. It earns a return on equity of 11.9%. The balance sheet holds a net cash position of 676M CNY. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥11.53 (bear case) to ¥19.07 (bull case); at ¥17.50, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 51% below its 52-week high and 18% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -48% fair-value upside, at -12%, 300435 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (¥32.67) versus Asset-Based (¥5.95). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 69 · Market factors (momentum, volatility) 33
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Hangzhou Zhongtai Cryogenic Technology Corporation develops, designs, manufactures, and sells cryogenic equipment in China.
Full company description
Hangzhou Zhongtai Cryogenic Technology Corporation develops, designs, manufactures, and sells cryogenic equipment in China. The company provides engineering services, such as natural gas engineering, air separation, syngas cryogenic separation, olefins separation, specialty gas, and chemical gas purification; manufacturers and sells plate-fin heat exchanger, spiral wound heat exchanger, cold box, distillation column, cryogenic vessel, and skid integration products; and offers EPC services, including natural gas liquefaction plant, natural gas processing plant, air separation plant, rare gas separation, and purification separation plant. It also exports its products to the United States, Europe, Africa, and Asia. Hangzhou Zhongtai Cryogenic Technology Corporation was founded in 2006 and is headquartered in Hangzhou, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Hangzhou Zhongtai Cryogenic Technology Corporation reported revenue of ¥2.8B in FY2025 versus ¥2.4B in FY2021, a compound +3.4%/yr. Reported net income was ¥450M in FY2025, compounding +16.4%/yr from FY2021.
300435 screens 12% overvalued. Compare with GE Vernova Inc →
Peer Group
Specialty Industrial Machinery · 809 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Industrial Machinery median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| GE Vernova Inc 1GEV | €887.60 | €186.93 | -79% |
| 1SIE 1SIE | €273.20 | €91.93 | -66% |
| SMNS SMNS | C$31.76 | C$22.68 | -29% |
| Eaton Corporation ETN | $407.28 | $171.92 | -58% |
| Atlas Copco AB ATCOA | kr 195.15 | kr 112.59 | -42% |
| Sandvik AB SAND | kr 384.10 | kr 193.01 | -50% |
| Doosan Enerbility Co 034020 | 76,400 KRW | 7,938 KRW | -90% |
| Vestas Wind Systems A/S VWS | kr 178.10 | kr 124.54 | -30% |
| Zhejiang Sanhua Intelligent Controls Co 002050 | ¥43.20 | ¥22.68 | -48% |
| NARI Technology Co 600406 | ¥22.19 | ¥18.71 | -16% |
Compare Hangzhou Zhongtai Cryogenic Technology Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Hangzhou Zhongtai Cryogenic Technology Corporation (300435) overvalued or undervalued?
What is the fair value of 300435?
What is the quality score of 300435?
What is the revenue of Hangzhou Zhongtai Cryogenic Technology Corporation (300435)?
What is the net profit margin of 300435?
Does Hangzhou Zhongtai Cryogenic Technology Corporation pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Hangzhou Zhongtai Cryogenic Technology Corporation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.